Joint Reconstruction Devices Market Size & Share 2026-2035

Joint Reconstruction Devices Market Size

The global joint reconstruction devices market was valued at USD 24.5 billion in 2025. The market is expected to reach USD 25.4 billion in 2026 to USD 40.6 billion in 2035, growing at a CAGR of 5.4% during the forecast period, according to the latest report published by Global Market Insights Inc.

The high market growth is attributed to the rising prevalence of musculoskeletal disorders such as osteoarthritis and rheumatoid arthritis, increasing geriatric population, growing adoption of minimally invasive joint replacement procedures, and continuous technological advancements in implant design and surgical techniques, among other contributing factors.

Joint reconstruction devices are orthopedic implants used to restore damaged or diseased joints, primarily in the knee, hip, shoulder, and ankle. These devices are widely utilized in managing degenerative joint diseases, trauma-related injuries, and other musculoskeletal conditions, helping to reduce pain, improve mobility, and enhance the overall quality of life for patients.

The major players in the global market are Zimmer Biomet, Stryker, Johnson & Johnson, Smith+Nephew, and Enovis. These companies maintain their competitive position through ongoing product innovation, strong global distribution networks, and substantial investments in advanced technologies such as robotic-assisted surgery, minimally invasive techniques, and next-generation implant materials designed to improve long-term clinical outcomes.

The market increased from USD 19 billion in 2022 to USD 23.1 billion in 2024, registering a historical growth rate of 10.1%. This growth was primarily attributed to the rising prevalence of osteoarthritis, rheumatoid arthritis, and sports-related injuries, particularly among the aging population. Additionally, the increasing adoption of minimally invasive procedures such as robot-assisted joint replacement surgeries, advancements in implant materials including biocompatible polymers and 3D-printed implants, and improving healthcare infrastructure have supported market expansion.

Furthermore, the growing incidence of joint disorders and injuries continues to drive demand for joint reconstruction devices globally. The increasing life expectancy in regions such as North America, Europe, and parts of Asia has led to a higher occurrence of age-related joint degeneration, thereby increasing the need for knee and hip replacement procedures. Moreover, the rise in obesity rates and active lifestyles has contributed to a surge in joint injuries and sports-related trauma, further fueling demand for reconstruction implants and related procedures.

Joint Reconstruction Devices Market Trends

The growing prevalence of age‑related musculoskeletal disorders, particularly osteoarthritis and rheumatoid arthritis, is significantly driving the demand for joint reconstruction procedures. The increasing proportion of elderly populations across North America, Europe, and parts of Asia is contributing to a higher incidence of joint degeneration, pain, and mobility limitations, thereby reinforcing joint replacement as a primary treatment option for restoring function and improving quality of life.

• Advancements in implant materials and surgical techniques represent another key trend influencing market evolution. The development of biocompatible materials such as advanced metals, ceramics, and highly cross‑linked polyethylene has enhanced implant durability, wear resistance, and long‑term performance. In parallel, the growing adoption of minimally invasive surgical techniques, along with robotic‑assisted and computer‑assisted systems, has improved surgical accuracy, reduced complication rates, and enabled faster recovery times, making joint reconstruction procedures more accessible and acceptable to a broader patient population, including elderly individuals.
• Additionally, progress in imaging and manufacturing technologies, including three‑dimensional (3D) imaging and computer‑aided design (CAD), is enabling the development of patient‑specific and customized implants tailored to individual anatomy. These personalized solutions improve implant alignment and fit, reduce the likelihood of complications, and enhance post‑surgical functional outcomes. The increasing integration of 3D printing technologies is further supporting the production of customized implants, particularly in complex and revision cases.

Joint Reconstruction Devices Market Analysis

Based on product type, the market is segmented into knee replacement, hip replacement, shoulder replacement, ankle replacement, elbow replacement, and other product types. The knee replacement segment has asserted its dominance in the market by securing a 45.1% market share  in 2025. The segment is expected to grow with a CAGR of 5.6% during the forecast period.

• The high prevalence of knee joint disorders, particularly osteoarthritis and rheumatoid arthritis, is a key factor driving the dominance of the knee replacement segment in the market. These conditions are highly age-related and increasingly common among the growing geriatric population, leading to significant pain, stiffness, and mobility limitations. As a result, knee replacement procedures have become the most widely performed joint reconstruction surgeries compared to hip, shoulder, and ankle replacements.
• Advancements in knee implant technologies and surgical techniques are further supporting segment expansion. The integration of robotic-assisted surgery, computer-guided navigation systems, and customized implant designs has enhanced surgical precision, implant alignment, and overall patient outcomes. In addition, minimally invasive approaches have reduced procedural complexity, shortened hospital stays, and accelerated recovery times, making knee replacement procedures more accessible and acceptable to a broader patient population.
• In addition, changing lifestyle patterns, including increasing rates of obesity and sedentary behavior, are contributing to higher stress on knee joints and accelerating joint degeneration. This trend is leading to a rise in early-onset knee disorders, thereby increasing the demand for knee replacement devices across both aging and younger populations.
• The hip replacement segment accounted for USD 7.4 billion in 2025 and is projected to expand at a CAGR of 5% from 2026 to 2035. The segmental growth is driven by the rising prevalence of hip osteoarthritis, increasing geriatric population, and the growing incidence of fractures, particularly among elderly patients.
• The shoulder replacement segment accounted for USD 2.3 billion in 2025 and is projected to expand at a CAGR of 6.1% from 2026 to 2035. The segmental growth is driven by the increasing incidence of shoulder injuries, rotator cuff disorders, and degenerative joint diseases.
• The ankle replacement segment accounted for USD 1.1 billion in 2025 and is projected to expand at a CAGR of 5.8% from 2026 to 2035. The segmental growth is driven by the increasing shift from ankle fusion procedures to total ankle replacement, particularly among active and younger patient populations.
• The elbow replacement segment is projected to expand at a CAGR of 4.7% from 2026 to 2035. The segmental growth is driven by the rising prevalence of rheumatoid arthritis, trauma-related injuries, and complex fractures requiring surgical intervention.

Based on fixation type, the joint reconstruction devices market is classified into cemented fixation, cementless (press-fit) fixation, hybrid fixation, and reverse hybrid fixation. The cementless (press-fit) fixation segment dominated the market with a revenue share of 36.2% in 2025.

• The segmental growth is driven by the increasing preference for biological fixation techniques, particularly among younger and active patient populations. Cementless implants enable bone ingrowth into porous-coated surfaces, providing long-term stability and reducing the risk of implant loosening, thereby making them a preferred choice in modern joint reconstruction procedures.
• Advancements in implant surface technologies and materials are further supporting segment expansion. Innovations such as porous coatings, hydroxyapatite coatings, and 3D-printed structures are enhancing osseointegration and improving implant longevity. These developments are particularly beneficial in knee and hip replacements, where long-term durability and performance are critical.
• In addition, the growing adoption of minimally invasive and robotic-assisted surgical techniques is contributing to the increased utilization of cementless fixation systems.
• The cemented fixation segment accounted for USD 7.3 billion in 2025 and is projected to grow at a CAGR of 5.2% over the forecast period. Growth is primarily driven by its widespread use in elderly patients with poor bone quality, where immediate implant stability is critical. Cemented fixation remains a preferred choice in complex cases and revision procedures, owing to its long clinical history, reliable outcomes, and ease of use in patients with compromised bone density.
• The hybrid fixation segment accounted for USD 5.6 billion in 2025 and is expected to expand at a CAGR of 5.4% from 2026 to 2035. This growth is attributed to the increasing preference for combining the advantages of both cemented and cementless fixation techniques, allowing optimized implant stability and long-term durability.
• The reverse hybrid fixation segment accounted for USD 2.7 billion in 2025 and is anticipated to grow at a CAGR of 3.6% during the forecast period. Demand is driven by its selective application in specific clinical scenarios that require tailored fixation strategies, particularly in younger patients or complex anatomies.

Based on surgery type, the joint reconstruction devices market is classified into traditional surgery, minimally invasive surgery, and computed assisted surgery. The computed assisted surgery segment is the fastest growing segment, with a CAGR of 5.7% over the forecast period.

• Growth is primarily driven by the increasing adoption of advanced surgical technologies, including robotic systems and navigation platforms, which enhance precision in implant positioning and improve overall clinical outcomes.
• The growing demand for improved surgical accuracy and reduced variability in joint replacement procedures is contributing to the expansion of this segment. Computer‑assisted systems enable better alignment, real‑time intraoperative guidance, and data-driven decision-making, thereby reducing the risk of complications and revision surgeries.
• In addition, increasing investments in healthcare infrastructure and the rising adoption of robotic platforms are accelerating the integration of computer‑assisted technologies in orthopedic procedures. These platforms are particularly gaining traction in knee and hip replacement surgeries, where precision is critical for long-term implant performance.
• Furthermore, the shift toward value-based healthcare and the emphasis on improving patient outcomes, shorter recovery times, and reduced hospital stays are supporting the adoption of computer‑assisted surgical techniques.
• The traditional surgery segment accounted for USD 13.4 billion in 2025 and is anticipated to grow at a CAGR of 5.3% during the forecast period. Demand is primarily driven by its continued use in complex joint reconstruction procedures and in healthcare settings with limited access to advanced surgical technologies. Traditional surgical approaches remain essential for handling intricate cases requiring direct visualization and manual intervention, particularly in developing regions.
• The minimally invasive surgery segment accounted for USD 8.6 billion in 2025 and is anticipated to grow at a CAGR of 5.4% during the forecast period. Demand is driven by the increasing preference for procedures that offer reduced surgical trauma, shorter hospital stays, and faster recovery times. Minimally invasive techniques are increasingly adopted in knee and hip replacements due to improved patient outcomes.

Based on end use, the joint reconstruction devices market is classified into hospitals, orthopedic specialty centers, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 54.4% in 2025.

• This growth is primarily driven by the availability of advanced surgical infrastructure, including robotic systems, imaging technologies, and specialized orthopedic operating rooms, which enable hospitals to perform a wide range of complex joint reconstruction procedures across major joints such as the knee, hip, and shoulder.
• The presence of highly skilled orthopedic surgeons, along with multidisciplinary care teams, further strengthens the segment’s growth. Hospitals are preferred for handling complex and high-risk cases, particularly in elderly patients with multiple comorbidities, where advanced expertise and immediate emergency support are critical for successful outcomes.
• In addition, hospitals offer comprehensive in-house care, including pre-operative evaluation, surgery, and extended post-operative management. This integrated approach supports better patient monitoring, rehabilitation, and pain management, which are crucial for joint reconstruction procedures that require long recovery periods.   
• The orthopedic specialty centers segment is anticipated to grow at a CAGR of 5.7% over the forecast period. Growth in this segment is driven by the increasing preference for specialized orthopedic facilities that offer focused expertise in joint reconstruction procedures.
• The ambulatory surgical centers segment is anticipated to grow at a CAGR of 6.3% over the forecast period. Growth in this segment is driven by the increasing shift of joint reconstruction procedures toward outpatient settings, supported by advancements in minimally invasive techniques and enhanced recovery protocols.

North America Joint Reconstruction Devices Market

North America dominated the global market with the highest market share of 43.3% in 2025.

• The U.S. market was valued at USD 7.8 billion and USD 8.7 billion in 2022 and 2023, respectively. The market size reached USD 9.9 billion in 2025, growing from USD 9.4 billion in 2024, and is anticipated to grow at a CAGR of 4.8% from 2026 to 2035.
• North America, particularly the U.S., represents a significant market for joint reconstruction devices, supported by the high prevalence of musculoskeletal disorders. Conditions such as osteoarthritis, rheumatoid arthritis, and osteoporosis are widely observed in the region, driven by factors including an aging population, high obesity rates, and sedentary lifestyles. This substantial disease burden continues to drive demand for joint reconstruction procedures, particularly knee, hip, and shoulder replacements.
• The increasing geriatric population across the U.S. and Canada is a key contributor to market growth, as older individuals are more susceptible to joint degeneration and mobility limitations. The rising need for effective pain management, restoration of mobility, and improved quality of life is encouraging the adoption of advanced joint reconstruction implants and procedures among elderly patients.
• The region benefits from a well-established healthcare infrastructure and widespread adoption of advanced surgical technologies, including robotic-assisted surgery, minimally invasive techniques, and computer-assisted navigation systems. These technological advancements enhance surgical accuracy, reduce recovery time, and improve patient outcomes, thereby reinforcing the adoption of joint reconstruction procedures across hospitals and specialty care centers.

Europe Joint Reconstruction Devices Market

Europe market accounted for USD 6.5 billion in 2025 and is anticipated to show lucrative growth over the forecast period.

• Europe represents a significant and steadily growing market for joint reconstruction devices, supported by the rising prevalence of musculoskeletal disorders across the region. In countries such as the U.K., a considerable proportion of the population aged 65 years and above suffers from conditions such as osteoarthritis, osteoporosis, and rheumatoid arthritis, leading to increased demand for joint replacement procedures, particularly hip and knee reconstruction surgeries aimed at improving mobility and reducing pain.
• Many European countries benefit from well‑established healthcare systems with universal or near‑universal coverage, ensuring broad patient access to advanced orthopedic care. The presence of national healthcare systems, such as the National Health Service (NHS) in the U.K., plays a key role in facilitating access to joint reconstruction procedures. Initiatives to reduce waiting times for elective surgeries are further supporting higher procedural volumes and increasing demand for joint reconstruction devices across hospitals and specialty centers.
• Additionally, the region is characterized by strong adoption of advanced surgical technologies, including robotic‑assisted procedures, minimally invasive techniques, and computer‑assisted navigation systems. Hospitals and specialized orthopedic centers across Europe are increasingly equipped with modern surgical infrastructure, enabling improved procedural outcomes, reduced recovery times, and enhanced patient satisfaction.

Asia Pacific Joint Reconstruction Devices Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 6.5% during the analysis timeframe.

• Asia Pacific represents a rapidly growing market for joint reconstruction devices, driven by significant demographic shifts and rising disease prevalence. Countries such as China, which holds a dominant position in the region, are witnessing a growing burden of musculoskeletal disorders, including osteoarthritis and osteoporosis, due to aging populations. In addition, increasing urbanization and more active lifestyles among younger populations are contributing to a higher incidence of joint injuries and chronic orthopedic conditions, thereby driving demand for joint reconstruction procedures.
• Healthcare systems across the region, particularly in key markets such as China, Japan, South Korea, and Australia, are undergoing rapid modernization and expansion. Governments are investing heavily in healthcare infrastructure and reforms, leading to improved access to advanced orthopedic care and an increased number of skilled medical professionals specializing in joint reconstruction procedures. This expansion is enabling a larger patient pool to access surgical treatments that were previously limited due to cost or infrastructure constraints.
• Additionally, technological advancements and the growing presence of domestic manufacturers are strengthening the market landscape. Local companies in countries such as China are increasingly producing cost-effective, high-quality joint implants, improving the accessibility and affordability of reconstruction devices. The adoption of advanced surgical techniques, including minimally invasive and robotic-assisted procedures, is also increasing across hospitals and specialty centers, supporting better patient outcomes and higher procedural volumes..

Latin America Joint Reconstruction Devices Market

The Latin America market is experiencing robust growth over the analysis timeframe.

• Latin America represents an emerging market for joint reconstruction devices, supported by the steady expansion of private healthcare facilities and orthopedic specialty centers across the region. Private hospitals in countries such as Brazil, Mexico, and Argentina are increasingly investing in advanced surgical infrastructure, including robotic systems, imaging technologies, and minimally invasive surgical capabilities to perform joint replacement procedures such as knee and hip reconstruction. This expansion of healthcare infrastructure is driving greater adoption of joint reconstruction devices.
• Additionally, ongoing improvements in healthcare access and referral networks are strengthening the diagnosis and treatment of musculoskeletal disorders across Latin America. The growing availability of orthopedic services in urban hospitals and specialty centers is enabling earlier diagnosis and timely intervention for conditions such as osteoarthritis, trauma-related injuries, and degenerative joint diseases, thereby increasing procedural volumes and device utilization.
• Furthermore, rising awareness of advanced treatment options and minimally invasive joint replacement procedures is supporting market growth. Patients are increasingly seeking surgical solutions that offer improved mobility, reduced pain, and faster recovery. Gradual increases in healthcare expenditure, along with private sector participation, are enhancing access to advanced orthopedic care and expanding the patient pool undergoing joint reconstruction procedures.

Middle East & Africa Joint Reconstruction Devices Market

The Middle East & Africa (MEA) market is expected to witness lucrative growth during the forecast period.

• The Middle East & Africa (MEA) market is experiencing steady growth over the analysis timeframe. The region represents a developing market for joint reconstruction devices, driven by the rising prevalence of lifestyle‑related and age‑associated musculoskeletal disorders. Factors such as increasing rates of obesity, diabetes, and sedentary lifestyles, particularly in Middle Eastern countries, are contributing to a higher incidence of osteoarthritis and joint degeneration, thereby driving demand for joint reconstruction procedures.
• Countries in the Gulf Cooperation Council (GCC), including Saudi Arabia and the UAE, are making substantial investments in healthcare infrastructure, including the development of advanced hospitals, orthopedic specialty centers, and tertiary care facilities. These investments are improving access to modern surgical technologies, including minimally invasive and robotic‑assisted joint replacement procedures, enabling more effective management of joint disorders and supporting increased adoption of reconstruction devices.
• Additionally, growing awareness regarding joint health, rising healthcare expenditure, and the presence of medical tourism hubs in the region are further supporting market expansion. Several private healthcare providers are offering advanced orthopedic procedures at competitive costs, attracting both local and international patients seeking joint reconstruction surgeries.

Joint Reconstruction Devices Market Share

The market is characterized by moderate to high competition, driven by continuous product innovation, expansion of orthopedic implant portfolios, and a strong focus on improving clinical outcomes and patient mobility. Manufacturers are actively investing in the development of advanced joint implants featuring enhanced durability, improved biocompatibility, and optimized designs that enable better joint function and longevity across knee, hip, shoulder, and other reconstruction procedures.

Key players in the market include Zimmer Biomet, Stryker, Johnson & Johnson (DePuy Synthes), Smith+Nephew, and Enovis, which collectively account for approximately ~68% of the total global market share. These companies maintain strong global distribution networks and long-standing relationships with hospitals, orthopedic surgeons, and specialty care centers.

In addition to major multinational players, several mid-tier and regional manufacturers, such as Medacta, MicroPort Scientific, Meril Life Sciences, and Exactech, contribute to market competition by offering innovative and cost-effective implant solutions. These companies often focus on specific product segments, technological niches, or price-sensitive markets, particularly in emerging economies. As healthcare infrastructure continues to expand globally and demand for minimally invasive and technologically advanced joint reconstruction procedures increases, competition in the market is expected to intensify.

Joint Reconstruction Devices Market Companies

A few of the prominent players operating in the joint reconstruction devices industry include:

• Auxein
• B. Braun
• Conformis
• Enovis
• Exactech
• Globus Medical
• GPC Medical
• Johnson & Johnson
• Medacta International
• Meril Life Sciences
• MicroPort Scientific
• NextStep Arthropedix
• Smith+Nephew
• Stryker
• Zimmer Biomet
• Johnson & Johnson

Johnson & Johnson holds a strong position in the market through its DePuy Synthes orthopedic division, which offers a comprehensive portfolio of hip, knee, and shoulder reconstruction solutions.

• Smith+Nephew

Smith+Nephew maintains a strong competitive position in the market through its balanced portfolio of knee, hip, and emerging shoulder reconstruction systems, supported by its growing focus on enabling technologies.

• Enovis

Enovis has established a notable presence in the market through its focus on high-growth extremities and reconstructive segments, particularly in shoulder and knee systems. The company’s portfolio, strengthened through the integration of DJO Surgical and LimaCorporate, includes advanced implant solutions such as reverse shoulder systems and 3D-printed implants.

Joint Reconstruction Devices Industry News:

• In February 2024, Smith+Nephew announced the full commercial launch of its AETOS Shoulder System in the U.S. and received FDA 510(k) clearance for its integration with advanced 3D planning software for total shoulder arthroplasty. This development enables improved surgical planning, enhanced implant positioning accuracy, and optimized clinical outcomes in shoulder reconstruction procedures. The launch strengthens Smith+Nephew’s shoulder portfolio and supports the growing adoption of technology-enabled joint replacement solutions in the U.S. market.
• In January 2024, Enovis Corporation completed the acquisition of LimaCorporate S.p.A., strengthening its position in the market. The acquisition enhances Enovis’ portfolio with advanced orthopedic implant solutions, including 3D-printed Trabecular Titanium technologies and comprehensive shoulder and revision systems. This strategic move expands Enovis’ presence in high-growth extremities segments, improves global scale, and supports long-term growth through expanded product offerings, innovation capabilities, and cross-selling opportunities in orthopedic reconstruction procedures.

The joint reconstruction devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Market, By Product Type

• Knee replacement devices  
  • Primary knee systems
  • Partial knee systems
  • Revision knee systems
• Hip replacement devices    
  • Total hip replacement (THR) implants
  • Partial hip replacement (Hemiarthroplasty) implants
  • Hip resurfacing implants
  • Revision hip  implants
• Shoulder replacement devices      
  • Total shoulder arthroplasty (TSA) implants
  • Reverse shoulder arthroplasty (RSA) implants
  • Partial shoulder replacement implants
• Ankle replacement devices 
  • Two-component fixed bearing
  • Three-component mobile bearing
• Elbow replacement devices 
  • Total elbow replacement
  • Partial elbow replacement
  • Revision elbow replacement
• Other product types

Market, By Fixation Type

• Cemented fixation
• Cementless (Press-Fit) fixation
• Hybrid fixation
• Reverse hybrid fixation

Market, By Surgery Type

• Traditional surgery
• Minimally invasive surgery
• Computed assisted surgery

Market, By End Use

• Hospitals
• Orthopedic specialty centers
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE